Urokinase-type-plasminogen-activator(UPA) production by human breast (MYO)fibroblasts in vitro: Influence of transforming growth factor-β1 (TGFβ1) compared with factor(S) released by human epithelial-carcinoma cells

International Journal of Cancer

Volumn 76, Issue 6, 1998, Pages 829-835

  Sieuwerts, Anieta M ^a   Klijn, Jan G M ^a   Henzen Logmans, Sonja C ^a   Bouwman, Ivo ^a   Van Roozendaal, Kees E P ^a   Peters, Harry A ^a   Setyono Han, Buddy ^a   Foekens, John A ^a  

^a ERASMUS MC CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1; UROKINASE;

ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER INVASION; HUMAN; HUMAN CELL; MYOFIBROBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA;

BREAST; BREAST NEOPLASMS; CELLS, CULTURED; FEMALE; FIBROBLASTS; HUMANS; NEOPLASMS, GLANDULAR AND EPITHELIAL; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; URINARY PLASMINOGEN ACTIVATOR;

EID: 0032503556     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980610)76:6<829::AID-IJC11>3.0.CO;2-Y     Document Type: Article

References (22)

1. ANDREASEN, P.A., KJØLLER, L., CHRISTENSEN, L. and DUFFY, M.J., The urokinase-type plasminogen-activator system in cancer metastasis: a review. Int. J. Cancer, 72, 1-22 (1997).
2. ARNOLETTI, J.P., ALBO, D., GRANICK, M.S., SOLOMON, M.P., CASTIGLIONI, A., ROTHMAN, V.L., and TUSZYNSKI, G.P., Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen-activator inhibitor-1 in human MDA-MB-231 breast-cancer cells. Cancer, 76, 998-1005 (1995).
3. BASSET, P., BELLOCQ, J.P., WOLF, C., STOLL, I., HUTIN, P., LIMACHER, J.M., PODHAJCER, O.L., CHENARD, M.P., RIO, M.C. and CHAMBON, P., A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature (Lond.), 348, 699-704 (1990).
4. CLARKE, R., DICKSON, R.B. and LIPPMAN, M.E., Hormonal aspects of breast cancer, growth factors, drugs and stromal interactions. Crit. Rev. Oncol. Hematol., 12, 1-23 (1992).
5. CULLEN, B., SILCOCK, D., BROWN, L.J., GOSIEWSKA, A. and GEESIN, J.C., The differential regulation and secretion of proteinases from fetal and neonatal fibroblasts by growth factors. Int. J. Biochem, Cell Biol., 29, 241-250 (1997).
6. DANØ, K., ANDREASEN, P.A., GRØNDAHL,-HANSEN, J., KRISTENSEN, P.I., NIELSEN, B.S. and SKRIVER, L., Plasminogen activators, tissue degradation and cancer. Advanc. Cancer Res., 44, 139-266 (1985).
7. DUFFY, M.J., O'GRADY, P., DEVANEY, D., O'SIORAIN, L., FENNELLY, J.J. and LIJNEN, H.J., Urokinase-plasminogen activator, a marker for aggressive breast carcinomas: preliminary report. Cancer, 62, 531-533 (1988).
8. GREBENSCHIKOV, N., GEURTS-MOESPOT, A., DE WITTE, H., HEUVEL, J., LEAKE, R., SWEEP, F. and BENRAAD, T., A sensitive and robust assay for urokinase and tissue-type plasminogen activators (uPA and tPA) and their inhibitor type I (PAI-I) in breast-tumor cytosols. Int. J. biol. Markers, 12, 6-14 (1997).
9. 22 production, in human synovial fibroblasts. Proc. nat. Acad. Sci. (Wash.), 88, 7180-7184 (1991).
10. HANNOCKS, M.-J., OLIVER, L., GABRILOVE, J.L. and WILSON, E.L., Regulation of proteolytic activity in human bone-marrow stromal cells by basic fibroblast growth factor, interleukin-1, and transforming growth factor beta. Blood, 79, 1178-1184 (1992).
11. KESKI-OJA, J., BLASI, R. LEOF, E.B. and MOSES, H.L., Regulation of the synthesis and activity of urokinase plasminogen activator in A549 human lung-carcinoma cells by transforming growth factor-β. J. Cell Biol., 106, 451-459 (1988).
12. LIOTTA, L.A., TRYGGVASON, K., GARBISA, S., HART, I., FOLTZ, C.M. and SHAFIE, S., Metastatic potential correlates with enzymatic degradation of basement-membrane collagen. Nature (Lond.), 284, 67-68 (1980).
13. LUND, L.R., RICCIO, A., ANDREASEN, P.A., NIELSEN, L.S., KRISTENSEN, P., LAIHO, M., SAKSELA, O., BLASI, F. and DANØ, K., Transforming growth factor-β is a strong and fast-acting positive regulator of the level of type-1-plasminogen-activator-inhibitor mRNA in WI-38 human lung fibroblasts. EMBO J., 6, 1281-1286 (1987).
14. NIELSEN, B.S., SEHESTED, M., TIMSHEL, S., PYKE, C. and DANØ, K., Messenger RNA for urokinase plasminogen activator is expressed in myofibroblasts adjacent to cancer cells in human breast cancer. Lab. Invest., 74, 168-177 (1996).
15. REISS, M. and BARCELLOS-HOFF, M.H., Transforming growth factor-β in breast cancer: a working hypothesis. Breast Cancer Res. Treat., 45, 81-95 (1997).
16. 1 in quiescent human breast gland fibroblasts. Lab. Invest., 68, 696-707 (1993).
17. RØNNOV-JESSEN, L., PETERSEN, O.W., KOTELIANSKY, V.E. and BISSELL, M.J., The origin of the myofibroblasts in breast cancer: recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth-muscle cells. J. clin. Invest., 95, 859-873 (1995).
18. SAPPINO, A.-P., SKALLI, O., JACKSON, W., SCHÜRCH, W. and GABBIANI, G., Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues. Int. J. Cancer, 41, 707-712 (1988).
19. SCHMITT, M., HARBECK, N., THOMSSEN, C., WILHELM, O., MAGDOLEN, V., REUSING, U., ULM, K., HÖKLER, H., JÄNICKE, F. and GRAEFF, H., Clinical impact of the plasminogen-activator system in tumor invasion and metastasis: prognostic relevance and target for therapy. Thromb. Hemost., 78, 285-296 (1997).
20. VAN ROOZENDAAL, C.E.P., KLIJN, J.G.M., SIEUWERTS, A.M., HENZEN-LOGMANS, S.C. and FOEKENS, J.A., Role of urokinase plasminogen activator in human breast cancer: active involvement of stromal fibroblasts. Fibrinolysis, 10 (Suppl. 2), 79-83 (1996).
21. VAN ROOZENDAAL, C.E.P., VAN OOIJEN, B., KLIJN, J.G.M., CLAASSEN, C., EGGERMONT, A.M.M., HENZEN-LOGMANS, S.C. and FOEKENS, J.A., Stromal influences on breast-cancer cell growth. Brit. J. Cancer, 65, 77-81 (1992).
22. WOLF, C., ROUER, N., LUTZ, Y., ADIDA, C., LORIOT, M., BELLOCQ, J.P., CHAMBON, P. and BASSET, P., Stromelysin 3 belongs to a sub-group of proteinases expressed in breast-carcinoma fibroblastic cells and possibly implicated in tumor progression. Proc. nat. Acad. Sci. (Wash.), 90, 1843-1847 (1993).